Top Markets
#1 MON MON +2,684.75%
#2 HOODIE HOODIE +44.24%
#3 Manifesting Manifesting +26.54%
#4 Vanar Chain Vanar Chain +17.50%
#5 Ardor Ardor +12.83%
#6 Threshold Network Threshold Network +10.87%
#7 Cortex Cortex +10.48%
#8 Synapse Synapse +10.28%
#9 Quai Network Quai Network +10.07%
#10 HashKey Platform Token HashKey Platform Token +9.92%
Coin of the day
MON MON
Settings
Language
ENGLISH
Currency
USD
Theme
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rank in Stocks #12697
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Share Price
$2.04
Market Cap
$122.58M
Change (1 day)
4.48%
Change (1 year)
-1.05%
Country
FR
Trade Crossject Société Anonyme (ALCJ)

Category

Healthcare
Revenue for Crossject Société Anonyme (ALCJ)
Revenue in Dec 2025 TTM: $1.74M
According to Crossject Société Anonyme latest financial reports the company's current revenue (TTM) is $1.74M. In 2023 the company made a revenue of $160.29K a decrease compared to the revenue in the year 2022 that was $1.02M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Crossject Société Anonyme from 2010 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $1.74M -59.37%
2024 $4.28M 2,571.33%
2023 $160.29K -84.34%
2022 $1.02M -1.33%
2021 $1.04M -82.42%
2020 $5.90M 951.59%
2019 $561.00K -80.03%
2018 $2.81M -27.63%
2017 $3.88M 159.26%
2016 $1.50M -13.08%
2015 $1.72M 2.76%
2014 $1.68M 30.22%
2013 $1.29M 176.01%
2012 $466.30K -44.58%
2011 $841.44K 214.68%
2010 $267.40K 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $10.58B 608,081.77%
US
EssilorLuxottica Société anonyme EssilorLuxottica Société anonyme
EssilorLuxottica Société anonyme
EL.PA
 $33.43B 1,921,073.30%
FR
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft
SOAGY.US
 $4.22B 242,477.69%
DE
HOYA Corporation HOYA Corporation
HOYA Corporation
HOCPY.US
 $6.27B 360,357.63%
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $21.37B 1,227,804.05%
US